HPWM
TMO icon

Highland Private Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Highland Private Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,395
Closed -$707K – 148
2022
Q3 		$707K Buy
1,395
+3
+0.2% +$1.68K 0.11% 70
2022
Q2 		$756K Buy
1,392
+23
+2% +$12.7K 0.12% 65
2022
Q1 		$809K Buy
1,369
+57
+4% +$32.7K 0.11% 65
2021
Q4 		$875K Buy
1,312
+5
+0.4% +$3.12K 0.11% 64
2021
Q3 		$747K Buy
1,307
+61
+5% +$33.5K 0.11% 73
2021
Q2 		$629K Buy
1,246
+25
+2% +$11.8K 0.09% 77
2021
Q1 		$558K Buy
1,221
+1
+0.1% +$477 0.09% 81
2020
Q4 		$568K Buy
1,220
+8
+0.7% +$3.75K 0.1% 72
2020
Q3 		$535K Sell
1,212
-297
-20% -$123K 0.11% 70
2020
Q2 		$547K Buy
1,509
+712
+89% +$239K 0.12% 64
2020
Q1 		$226K Buy
797
+78
+11% +$24.6K 0.06% 100
2019
Q4 		$233K Buy
719
+12
+2% +$3.64K 0.06% 112
2019
Q3 		$206K Buy
707
+3
+0.4% +$859 0.06% 115
2019
Q2 		$207K Buy
+704
New +$194K 0.06% 115

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Highland Private Wealth Management's TMO Position: Q4 2022 in Review

Highland Private Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q4 2022, closing a stake of 1,395 shares — an estimated $707K sold.

Highland Private Wealth Management first reported a position in TMO in Q2 2019 and held it in 14 quarters. The position peaked at $875K in Q4 2021. 2,375 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

  • Highland Private Wealth Management reported no remaining Thermo Fisher Scientific position as of Q4 2022 after selling out during the quarter.
  • Highland Private Wealth Management sold 1,395 Thermo Fisher Scientific shares in Q4 2022, an estimated $707K.
  • Highland Private Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 14 quarters.
  • Highland Private Wealth Management's Thermo Fisher Scientific position peaked at $875K in Q4 2021.
  • 2,375 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Highland Private Wealth Management's 13F filing for Q4 2022.